07:00 , May 28, 2015 |  BC Innovations  |  Product R&D

A question of color

The metabolic benefits of FGF21 that prompted at least five companies to pursue it for weight loss were thought to lie in the hormone's ability to cause browning of white fat. But two independent studies...
07:00 , May 15, 2000 |  BC Week In Review  |  Company News

Senomyx, Johns Hopkins University deal

Johns Hopkins granted Senomyx rights to U.S. Patent No. 5,693,756 covering forms of amiloride sensitive sodium channels and potential methods for identifying substances that stimulate or block salty taste perception. (Ambryx becomes Senomyx, B7) Senomyx...
07:00 , May 15, 2000 |  BC Week In Review  |  Company News

Ambryx enabling technology news

The company, which develops products related to chemosensation, changed its name to Senomyx Inc. (Senomyx deal, B4; Board, B8; SAB, B9) Ambryx Inc., La Jolla, Calif.   Business: Enabling technology  ...
07:00 , May 9, 2000 |  BC Extra  |  Company News

Senomyx obtains license

Johns Hopkins University granted Senomyx (La Jolla, Calif.) rights to U.S. Patent No. 5,693,756 covering forms of amiloride sensitive sodium channels and potential methods for identifying substances that stimulate or block salty taste perception. Senomyx...
07:00 , Apr 10, 2000 |  BC Week In Review  |  Company News

Harvard Medical School other research news

Harvard researchers published in Nature the identification of the TRB family of G protein-coupled receptors (GPCRs) expressed in taste receptor cells. TRB genes were associated with genetic loci linked to bitter taste sensation, and different...
08:00 , Mar 27, 2000 |  BC Week In Review  |  Company News

University of California other research news

UCSD researchers and colleagues published in Cell the identification of the T2R family of 40-80 human and rodent GPCRs expressed in taste receptor cells. The researchers noted that the receptors are genetically linked to loci...
08:00 , Mar 20, 2000 |  BC Week In Review  |  Company News

Ambryx, University of California deal

Ambryx acquired rights from the university to T2R and T1R, families of candidate G protein-coupled receptors for taste. Ambryx Inc., San Diego, Calif.   University of California, San Diego, Calif.   Business: Neurological  ...
08:00 , Mar 17, 2000 |  BC Extra  |  Company News

Ambryx obtains taste receptor rights

Ambryx (San Diego, Calif.) acquired rights to a new family of candidate taste receptors, T2Rs, from the University of California, San Diego. The T2Rs, which include more than 40 genes, function as bitter taste receptors....
08:00 , Feb 22, 2000 |  BC Extra  |  Financial News

Bay City Capital closes NANAF

Bay City closed its $145 million North American Nutrition and Agribusiness Fund (NANAF), which invests in the nutrition and agribusiness sectors in North America. Limited partners in the fund include Novartis Agribusiness Biotechnology Research; General...
08:00 , Nov 1, 1999 |  BC Week In Review  |  Company News

Ambryx, Harvard University, Johns Hopkins University, Rockefeller University deal

Ambryx entered into three separate agreements focused on cancer. The company received an exclusive option to license Harvard's DNA sequences and related chemosensory receptor proteins and received an exclusive license from Johns Hopkins to an...